Critical Cybersecurity Vulnerabilities in Contec and Epsimed Patient Monitors

Critical Cybersecurity Vulnerabilities in Contec and Epsimed Patient Monitors

First seen 20 Apr 2026, 14:57 UTC www.fda.govdigital.nhs.uk 81% similarity 72.0

Article Content

Browse articles
ThreatCluster

The FDA and CISA have issued advisories regarding significant cybersecurity vulnerabilities in Contec CMS8000 and Epsimed MN-120 patient monitors. These devices are at risk due to a backdoor in their firmware, which allows unauthorized access and potential manipulation of patient data. The vulnerabilities include remote code execution and data exfiltration to a hard-coded public IP address. Affected organizations are urged to implement mitigations as these vulnerabilities could lead to severe breaches of patient confidentiality. Currently, there are no reported incidents of exploitation, but the potential for abuse remains high. The FDA has mandated that affected devices be used only for local monitoring, eliminating their internet connectivity. The vulnerabilities could affect a wide range of healthcare facilities using these monitors. CISA has recommended reviewing their advisory for further guidance.

Key Points: • Contec CMS8000 and Epsimed MN-120 patient monitors have critical vulnerabilities. • A backdoor in the firmware allows unauthorized access and data exfiltration. • The FDA has restricted the devices to local monitoring only, removing internet capabilities.

ThreatCluster AI

Timeline

2025-01-30
FDA issued initial safety communication regarding vulnerabilities.
2026-04-20
CISA published advisory detailing vulnerabilities in patient monitors.
2026-04-20
FDA updated safety communication following Contec's software patch.

Community

Browse all →